BackDrugs Made In America Acquisition Rights Overview

Drugs Made In America Acquisition Rights Goodwill

Track Drugs Made In America Acquisition Rights's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Drugs Made In America Acquisition Rights Goodwill History

Loading

Drugs Made In America Acquisition Rights vs. peers: Goodwill Comparison

Loading

Drugs Made In America Acquisition Rights Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Drugs Made In America Acquisition Rights (DMAAR) FAQ

As of the most recent data (June 2026), DMAAR shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMAAR's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Drugs Made In America Acquisition Rights is outperforming or lagging.

Tracking DMAAR's goodwill over time shows whether Drugs Made In America Acquisition Rights is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Drugs Made In America Acquisition Rights's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.